In multivariate analyses of OS and EFS including site, stage, VEGFR2, PDGFRs (α and β) and c-Kit, tumor stage III-IV (P<0.01) and high expression of VEGFR2 (p=0.02), were significant independent prognostic indicators for OS. This evidence concerns the gene KIT and neoplasm.